Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001438533-19-000011
Filing Date
2019-05-07
Accepted
2019-05-07 17:08:00
Documents
89
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rtrx-20190331x10q.htm 10-Q 1128233
2 EXHIBIT 31.1 ex03312019311.htm EX-31.1 18453
3 EXHIBIT 31.2 ex03312019312.htm EX-31.2 18548
4 EXHIBIT 32.1 ex03312019321.htm EX-32.1 11255
5 EXHIBIT 32.2 ex03312019322.htm EX-32.2 11427
12 productpiplinegraphq12019a01.jpg GRAPHIC 70689
  Complete submission text file 0001438533-19-000011.txt   6073682

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rtrx-20190331.xml EX-101.INS 1095362
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rtrx-20190331.xsd EX-101.SCH 52372
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rtrx-20190331_cal.xml EX-101.CAL 95796
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rtrx-20190331_def.xml EX-101.DEF 224590
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rtrx-20190331_lab.xml EX-101.LAB 635712
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rtrx-20190331_pre.xml EX-101.PRE 391106
Mailing Address 3721 VALLEY CENTRE DR. SUITE 200 SAN DIEGO CA 92130
Business Address 3721 VALLEY CENTRE DR. SUITE 200 SAN DIEGO CA 92130 760-260-8600
Retrophin, Inc. (Filer) CIK: 0001438533 (see all company filings)

EIN.: 262383102 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36257 | Film No.: 19804094
SIC: 2834 Pharmaceutical Preparations